News tagged with rosiglitazone

Epoxide hydrolase inhibition and Thiazolidinediones: A therapy for cardiometabolic syndrome

Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with ...

Diseases, Conditions, Syndromes Apr 23, 2013 | not rated yet | 1

Thiazolidinediones tied to lower cancer risk in diabetes patients

(HealthDay) -- Thiazolidinediones are associated with a lower risk of liver and colorectal cancer in patients with type 2 diabetes, according to a study published in the May issue of Hepatology.

Cancer Apr 27, 2012 | not rated yet | 0